Home Health F.D.A. Approves the Drug Daraxonrasib That’s Poised to...
Health

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Key Points

Daraxonrasib, the first drug of its type, has electrified pancreatic cancer specialists and patients because it has shown it can double life expectancy.

Daraxonrasib, the first drug of its type, has electrified pancreatic cancer specialists and patients because it has shown it can double life expectancy.
the Drug Daraxonrasib (ORG)
Originally published by NYT Business Read original →